Finaset 5 mg Filmdragerad tablett

Land: Sverige

Språk: svenska

Källa: Läkemedelsverket (Medical Products Agency)

Köp det nu

Bipacksedel Bipacksedel (PIL)
20-04-2018
Produktens egenskaper Produktens egenskaper (SPC)
20-04-2018

Aktiva substanser:

finasterid

Tillgänglig från:

Teva B.V.

ATC-kod:

G04CB01

INN (International namn):

finasteride

Dos:

5 mg

Läkemedelsform:

Filmdragerad tablett

Sammansättning:

laktosmonohydrat Hjälpämne; finasterid 5 mg Aktiv substans

Klass:

Apotek

Receptbelagda typ:

Receptbelagt

Terapiområde:

Finasterid

Produktsammanfattning:

Förpacknings: Blister, 7 tabletter (Al); Blister, 14 tabletter (Al); Blister, 28 tabletter (Al); Blister, 30 tabletter (Al); Blister, 49 tabletter (Al); Blister, 50 tabletter (Al); Blister, 98 tabletter (Al); Blister, 100 tabletter (Al); Blister, 300 tabletter (Al); Blister, 7 tabletter (Al/PVC); Blister, 14 tabletter (Al/PVC); Blister, 28 tabletter (Al/PVC); Blister, 30 tabletter (Al/PVC); Blister, 49 tabletter (Al/PVC); Blister, 50 tabletter (Al/PVC); Blister, 98 tabletter (Al/PVC); Blister, 100 tabletter (Al/PVC); Blister, 300 tabletter (Al/PVC); Burk, 10 tabletter; Burk, 30 tabletter; Burk, 50 tabletter; Burk, 100 tabletter; Burk, 300 tabletter; Blister, 10 tabletter (Al); Blister, 10 tabletter (Al/PVC); Blister, 20 tabletter (Al); Blister, 20 tabletter (Al/PVC); Blister, 60 tabletter (Al); Blister, 60 tabletter (Al/PVC)

Bemyndigande status:

Godkänd

Tillstånd datum:

2006-02-17

Bipacksedel

                                PACKAGE LEAFLET: INFORMATION FOR THE USER
FINASET 5 MG FILM COATED TABLETS
Finasteride
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Finaset is and what it is used for
2.
What you need to know before you take Finaset
3.
How to take Finaset
4.
Possible side effects
5.
How to store Finaset
6.
Contents of the pack and other information 1.
WHAT FINASET IS AND WHAT IT IS USED FOR
Finaset contains the active substance finasteride which belongs to a
group of medicines called ‘5-alpha
reductase inhibitors’. They act by reducing the size of the prostate
gland in men.
Finaset is used in the treatment and control of benign (not cancerous)
_ _
enlargement of the prostate.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE FINASET
DO NOT TAKE FINASET:
-
if you are allergic to finasteride or any of the other ingredients of
this medicine (listed in section
6).
-
if you are a woman or a child (see also ‘Pregnancy and
breast-feeding’ in this section).
WARNINGS AND PRECAUTIONS
Talk to your doctor or pharmacist before taking Finaset
-
if you have reduced liver function.
-
if you have difficulty emptying your bladder completely or a greatly
reduced flow of urine, your
doctor should examine you thoroughly
_ _
before you start taking Finaset to exclude other
obstructions in the urinary tract.
-
if you notice any changes in your breast tissue such as lumps, pain,
enlargement of the breast
tissue or nipple discharge as these may be signs of a serious
condition, such as breast cancer.
You should promptly report to your 
                                
                                Läs hela dokumentet
                                
                            

Produktens egenskaper

                                MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_
                                
                                Läs hela dokumentet
                                
                            

Dokument på andra språk

Bipacksedel Bipacksedel engelska 12-03-2024
Produktens egenskaper Produktens egenskaper engelska 18-05-2020
Offentlig bedömningsrapport Offentlig bedömningsrapport engelska 28-01-2013